e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Pathobiology of experimental pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Right lung ischemia induces development of contra-lateral pulmonary vasculopathy
E. Sage, O. Mercier, P. Dartevelle, S. Eddahibi, E. Fadel (Le Plessis Robinson, France)
Source:
Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Session:
Pathobiology of experimental pulmonary hypertension
Session type:
Oral Presentation
Number:
3435
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Sage, O. Mercier, P. Dartevelle, S. Eddahibi, E. Fadel (Le Plessis Robinson, France). Right lung ischemia induces development of contra-lateral pulmonary vasculopathy. Eur Respir J 2011; 38: Suppl. 55, 3435
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury
Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant
Year: 2011
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models
Year: 2011
Systemic neovascularization of the lung after left pulmonary artery obstruction
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
Left atrial volume to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to left heart disease
Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Year: 2011
Myocardial deformation of right ventricle walls in patients with various forms of pulmonary hypertension
Source: Annual Congress 2010 - Vascular and haemodynamics
Year: 2010
Right ventricular output in chronic obstructive pulmonary disease during expiration is impaired by reduced venous return
Source: Annual Congress 2011 - Cardio-pulmonary interactions
Year: 2011
Prolonged overcirculation-induced pulmonary arterial hypertension, as a cause of right ventricular failure
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011
Predominant thrombus in right upper lung might induce hypoxemia in chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
Developing pulmonary rehabilitation in interstitial lung disease
Source: Annual Congress 2010 - PG22 Postgraduate Course: Developing pulmonary rehabilitation in non-COPD patients
Year: 2010
Pulmonary hypertension by right heart catheterization in patients with interstitial lung diease
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Systemic inflammation and NF-κB-dependent muscle atrophy in response to acute pulmonary inflammation
Source: Annual Congress 2010 - Respiratory and peripheral muscles: From basic mechanisms to altered function
Year: 2010
Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi
Source: Eur Respir J, 56 (5) 2000538; 10.1183/13993003.00538-2020
Year: 2020
Awake videothoracoscopic biopsy of diffuse lung disease. Effects on pulmonary function and oxygenation
Source: Annual Congress 2010 - Vascular and haemodynamics
Year: 2010
Surgical treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 735-742
Year: 2013
From alveolar haemorrhage to pulmonary renal syndrome
Source: Annual Congress 2011 - Vasculitis and the lung
Year: 2011
Pulmonary vascular injury, repair and remodelling in COPD patients
Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD
Year: 2010
The PPAR-β/δ agonist GW0742 reverses right venticular hypertrophy in a chronically hypoxic rat model of pulmonary hypertension
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010
Myocarditis of the right and left ventricle following acute pulmonary embolism
Source: Eur Respir J 2007; 30: Suppl. 51, 487s
Year: 2007
Pulmonary hypertensive vasculopathy in parenchymal lung diseases and/or hypoxia
Source: Eur Respir Rev, 26 (144) 170003; 10.1183/16000617.0003-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept